These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 26426815)
21. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R. Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864 [TBL] [Abstract][Full Text] [Related]
22. Role of angiotensin II in retinal leukostasis in the diabetic rat. Chen P; Scicli GM; Guo M; Fenstermacher JD; Dahl D; Edwards PA; Scicli AG Exp Eye Res; 2006 Nov; 83(5):1041-51. PubMed ID: 16822509 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488 [TBL] [Abstract][Full Text] [Related]
24. TRPV4 inhibition prevents increased water diffusion and blood-retina barrier breakdown in the retina of streptozotocin-induced diabetic mice. Orduña Ríos M; Noguez Imm R; Hernández Godínez NM; Bautista Cortes AM; López Escalante DD; Liedtke W; Martínez Torres A; Concha L; Thébault S PLoS One; 2019; 14(5):e0212158. PubMed ID: 31048895 [TBL] [Abstract][Full Text] [Related]
25. Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat. Ma P; Luo Y; Zhu X; Ma H; Hu J; Tang S Biochem Biophys Res Commun; 2009 Mar; 380(2):402-6. PubMed ID: 19250642 [TBL] [Abstract][Full Text] [Related]
26. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Feit-Leichman RA; Kinouchi R; Takeda M; Fan Z; Mohr S; Kern TS; Chen DF Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4281-7. PubMed ID: 16249509 [TBL] [Abstract][Full Text] [Related]
27. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy. Kim D; Mecham RP; Nguyen NH; Roy S Exp Eye Res; 2019 Jul; 184():221-226. PubMed ID: 31022398 [TBL] [Abstract][Full Text] [Related]
28. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia. Frank RN; Amin R; Kennedy A; Hohman TC Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227 [TBL] [Abstract][Full Text] [Related]
29. Diabetic retinopathy alters light-induced clock gene expression and dopamine levels in the mouse retina. Lahouaoui H; Coutanson C; Cooper HM; Bennis M; Dkhissi-Benyahya O Mol Vis; 2016; 22():959-69. PubMed ID: 27559292 [TBL] [Abstract][Full Text] [Related]
30. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model. Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451 [TBL] [Abstract][Full Text] [Related]
31. Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats. Sugawara R; Hikichi T; Kitaya N; Mori F; Nagaoka T; Yoshida A; Szabo C Curr Eye Res; 2004 Jul; 29(1):11-6. PubMed ID: 15370362 [TBL] [Abstract][Full Text] [Related]
32. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes. Lee VK; Hosking BM; Holeniewska J; Kubala EC; Lundh von Leithner P; Gardner PJ; Foxton RH; Shima DT Diabetologia; 2018 Nov; 61(11):2422-2432. PubMed ID: 30094465 [TBL] [Abstract][Full Text] [Related]
33. Roles for redox signaling by NADPH oxidase in hyperglycemia-induced heme oxygenase-1 expression in the diabetic retina. He M; Pan H; Xiao C; Pu M Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4092-101. PubMed ID: 23633655 [TBL] [Abstract][Full Text] [Related]
34. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina. Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055 [TBL] [Abstract][Full Text] [Related]
35. Considerations for the Use of Photobiomodulation in the Treatment of Retinal Diseases. Zhang CX; Lou Y; Chi J; Bao XL; Fan B; Li GY Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551239 [TBL] [Abstract][Full Text] [Related]
36. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo. Jiang S; Chen X Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154 [TBL] [Abstract][Full Text] [Related]
37. A central role for inflammation in the pathogenesis of diabetic retinopathy. Joussen AM; Poulaki V; Le ML; Koizumi K; Esser C; Janicki H; Schraermeyer U; Kociok N; Fauser S; Kirchhof B; Kern TS; Adamis AP FASEB J; 2004 Sep; 18(12):1450-2. PubMed ID: 15231732 [TBL] [Abstract][Full Text] [Related]
38. Protective Effects of Leukemia Inhibitory Factor on Retinal Vasculature and Cells in Streptozotocin-induced Diabetic Mice. Yang XF; Huang YX; Lan M; Zhang TR; Zhou J Chin Med J (Engl); 2018 Jan; 131(1):75-81. PubMed ID: 29271384 [TBL] [Abstract][Full Text] [Related]
39. Mechanistic Insights into Pathological Changes in the Diabetic Retina: Implications for Targeting Diabetic Retinopathy. Roy S; Kern TS; Song B; Stuebe C Am J Pathol; 2017 Jan; 187(1):9-19. PubMed ID: 27846381 [TBL] [Abstract][Full Text] [Related]
40. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Zheng L; Du Y; Miller C; Gubitosi-Klug RA; Kern TS; Ball S; Berkowitz BA Diabetologia; 2007 Sep; 50(9):1987-1996. PubMed ID: 17583794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]